Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Bluebird Bio Stock Quote

Bluebird Bio (NASDAQ: BLUE)

Price as of November 30, 2023, 12:18 p.m. ET

You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Bluebird Bio Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
BLUE -49.54% -95.15% -45.40% -78%
S&P +14.98% +64.87% +10.52% +179%

Bluebird Bio Company Info

Bluebird Bio is a development-stage biotechnology company focused on gene therapy, gene editing, and cancer immunotherapy.

News & Analysis

The Fool has written over 300 articles on Bluebird Bio.


Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.